Cel Sci Corporation (CVM)

[meirluc]

has anyone on this MB have an educated or uneducated guess as to how many of the trial's 795 patients have ended up as LTFU (dropouts)?

With so many third world countries participating in the multikine trial, keeping the numbers of LTFU low would seem to be of paramount importance.

Geert's optimism suggests that the numbers of LTFU were not large enough to
jeopardize the results which are likely to be very positive. Still I was hoping for more discussions on this MB about the possible numbers of LTFU that may modify the results of this trial.

Has anybody information as to if and to what extent the IDMC plays
a role in addressing the potential problem of large numbers of LTFU affecting the outcome of clinical trials?